These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23704051)

  • 1. Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
    de Luis DA; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; de la Fuente B
    Diabetes Metab Res Rev; 2013 Oct; 29(7):576-81. PubMed ID: 23704051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of serum resistin levels with metabolic syndrome criteria in obese female patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Primo D
    Clin Biochem; 2011 Nov; 44(16):1280-3. PubMed ID: 21939645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between visfatin and serum concentrations of C-reactive protein, interleukin 6 in patients with metabolic syndrome.
    Hosseinzadeh-Attar MJ; Golpaie A; Foroughi M; Hosseinpanah F; Zahediasl S; Azizi F
    J Endocrinol Invest; 2016 Aug; 39(8):917-22. PubMed ID: 27023106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
    Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adipokine visfatin is markedly elevated in obese children.
    Haider DG; Holzer G; Schaller G; Weghuber D; Widhalm K; Wagner O; Kapiotis S; Wolzt M
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):548-9. PubMed ID: 17033537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma visfatin and tumor necrosis factor-alpha (TNF-α) levels in metabolic syndrome.
    Olszanecka-Glinianowicz M; Kocełak P; Janowska J; Skorupa A; Nylec M; Zahorska-Markiewicz B
    Kardiol Pol; 2011; 69(8):802-7. PubMed ID: 21850623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.
    Filippatos TD; Tsimihodimos V; Derdemezis CS; Gazi IF; Saougos V; Mikhailidis DP; Tselepis AD; Elisaf MS
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):330-6. PubMed ID: 21963513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Visfatin in obese patients, relation with cardiovascular risk factors, a cross sectional study].
    de Luis DA; Ballesteros M; Ruiz E; Muñoz C; Penacho A; Iglesias P; Guzmán AL; Abreu C; Maldonado A; Delgado M; Martín LS; Puigdevall V; Romero E; Sagrado MG; Izaola O; Conde R;
    Med Clin (Barc); 2011 Jul; 137(5):199-203. PubMed ID: 21296365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
    Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
    Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.
    de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
    Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
    Huang JF; Huang CF; Yu ML; Dai CY; Huang CI; Yeh ML; Hsieh MH; Yang JF; Hsieh MY; Lin ZY; Chen SC; Chuang WL
    J Gastroenterol Hepatol; 2011 Mar; 26(3):530-5. PubMed ID: 21332548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of visfatin levels with insulin resistance and left ventricular hypertrophy in peritoneal dialysis patients.
    Karakan S; Sezer S; Özdemir Acar FN; Haberal M
    Ren Fail; 2012; 34(6):732-7. PubMed ID: 22503095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body fat distribution has no effect on serum visfatin levels in healthy female subjects.
    Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S
    Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.
    Chen CC; Li TC; Li CI; Liu CS; Lin WY; Wu MT; Lai MM; Lin CC
    Metabolism; 2007 Sep; 56(9):1216-20. PubMed ID: 17697864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.